Posted by seminars in
Seminar on 09 6th, 2011 |
No Comments
Reversible self-assembly of protein nanoclusters
Protein drugs delivered via subcutaneous injection represent some of the most promising therapies for a variety of diseases, including treatment of cancer. However, a major challenge for this technology is how to reliably formulate concentrated (>250 mg/ml), low viscosity (i.e., syringeable) solutions...